FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to vaccines for treating and/or preventing the diseases caused by choroidal neovascularisation (neovascular maculopathy), which contain peptides derived from VEGFR2, as the active ingredient.
EFFECT: vaccination with the use of this peptide as an antigen is effective to inhibit choroidal neovascularisation.
8 cl, 4 dwg
| Title |
Year |
Author |
Number |
| TREATMENT OF CHOROIDAL NEOVASCULARISATION BY MEANS OF VACCINES |
2010 |
- Tsudzikava Motokadzu
- Nakamura Jusuke
- Tsunoda Takuja
|
RU2555345C2 |
| COMBINED THERAPY OF PANCREATIC CANCER WITH USE OF ANTIGEN POLYPEPTIDE AND CHEMOTHERAPEUTIC AGENT |
2008 |
|
RU2472522C2 |
| PEPTID, OBTAINED FROM HSP70, A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER, CONTAINING SUCH PEPTID, IMMUNE RESPONSE INDUCTOR AND METHOD FOR OBTAINING ANTIGEN-PRESENTING PATH |
2015 |
- Udaka, Keiko
- Tamada, Koji
- Hazama, Shoichi
- Oka, Masaaki
- Miyakawa, Tomoya
|
RU2684911C2 |
| MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THEM |
2009 |
- Tsunoda Takuja
- Okhsava Rjudzi
|
RU2496787C2 |
| TEM8 PEPTIDES AND VACCINES CONTAINING THEM |
2008 |
- Tsunoda Takuja
- Osava Rjudzi
|
RU2498993C2 |
| PEPTIDE OBTAINED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING IT, IMMUNITY INDUCER AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS |
2016 |
- Udaka, Keiko
- Tamada, Koji
- Hazama, Shoichi
- Oka, Masaaki
- Miyakawa, Tomoya
|
RU2714117C2 |
| FOXP3 PEPTIDE VACCINE |
2007 |
- Tsunoda Takuja
- Osava Rjudzi
|
RU2473557C2 |
| PEPTIDE VACCINES FOR CANCER EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES |
2007 |
- Fudzioka Tomoaki
- Nakamura Jusuke
- Tsunoda Takuja
- Osava Rjudzi
- Sida Midori
|
RU2469044C2 |
| CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING SAME |
2009 |
- Tsunoda Takuja
- Okhsava Rjudzi
- Josimura Satiko
|
RU2502740C2 |
| UBE2T PEPTIDE AND VACCINES CONTAINING THE SAME |
2013 |
- Tsunoda Takuya
- Osava Ryudzi
- Josimura Satiko
- Vatanabe Tomokhisa
|
RU2663350C2 |
